enzalutamide
Showing 1 - 25 of 394
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
- Enzalutamide
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)
Not yet recruiting
- Androgen Deprivation Therapy
- Locally Advanced Prostate Cancer
- Relugolix and Enzalutamide
-
Oklahoma City, OklahomaStephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
- Enzalutamide
- M9241
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)
Recruiting
- Metastatic Breast Cancer
- Enzalutamide
- +2 more
-
Birmingham, Alabama
- +5 more
Oct 19, 2023
Darolutamide, Enzalutamide and Apalutamide and How Well These
Not yet recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Apalutamide
- +2 more
-
Whippany, New JerseyBayer
Aug 25, 2023
Medicines Called Enzalutamide and Abiraterone in People With
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Enzalutamide
- Abiraterone acetate
-
New York, New YorkPfizer Inc
Jul 21, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 12, 2023
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)
Not yet recruiting
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Enzalutamide 40 MG
- Docetaxel injection
- (no location specified)
Jan 27, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)
Terminated
- Metastatic Castration-resistant Prostate Cancer
- Enzalutamide during Lead-in Period
- +5 more
-
Myrtle Beach, South CarolinaResearch Site
Sep 9, 2022
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,
Recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Enzalutamide 40mg
- +4 more
-
Bellinzona, Switzerland
- +1 more
Nov 6, 2023
Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)
Recruiting
- Prostate Cancer
- Enzalutamide
- EPI-7386 with Enzalutamide
-
Port Saint Lucie, Florida
- +8 more
Dec 13, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Prostatic Tumors Trial in New York, Myrtle Beach, Houston (ORIC-101, enzalutamide 40 MG oral capsule [Xtandi])
Active, not recruiting
- Prostatic Neoplasms
- ORIC-101
- enzalutamide 40 MG oral capsule [Xtandi]
-
New York, New York
- +2 more
Sep 22, 2022
Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-F/TRICOM, PROSTVAC-V/TRICOM, Enzalutamide (Xtandi))
Active, not recruiting
- Prostate Cancer
- PROSTVAC-F/TRICOM
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
- enzalutamide
- CRLX101
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Called DEAR, to Learn More About Treatment With Darolutamide,
Active, not recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Whippany, New JerseyBayer
Jan 13, 2023
Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)
Not yet recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Standard of Care SBRT and ADT
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 6, 2022
Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone
Recruiting
- Castration Resistant Metastatic Prostate Cancer
- Testosterone cypionate
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022
Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Castration-resistant Prostate Cancer
- Docetaxel
- Enzalutamide
-
São Paulo, SP, BrazilInstituto do Câncer do Estado de São Paulo
Sep 14, 2022
Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- Enzalutamide
- Androgen deprivation therapy (ADT)
-
Ahmedabad, India
- +7 more
Jan 21, 2023
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
- Enzalutamide
- Ribociclib
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023